IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 2015'.
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
IOL Chemicals and Pharmaceuticals Limited has informed the exchanges that its Promoter Group entity, NCVI Enterprises Limited, has bought 7,00,000 equity shares of the company on 16 March 2026 through on-market purchases. Following this acquisition, NCVI Enterprises' holding has increased from 4,68,50,695 shares (15.96%) to 4,75,50,695 shares (16.20%) of the paid-up equity share capital. The disclosure has been filed under Regulation 7(2) of the SEBI Insider Trading Regulations, which requires continual disclosure of changes in shareholding by promoters and related persons. The transaction was reported to the company on 18 March 2026, and the filing is signed by Abhiraj Gupta, Director of NCVI Enterprises Limited.
This is a modest on-market purchase (around 0.24% increase in stake) by a Promoter Group entity, which is generally read as a positive confidence signal but is too small on its own to materially move the stock price.